Becton Dickinson and Company (BDX)vsMiniMed Group, Inc. Common Stock (MMED)
BDX
Becton Dickinson and Company
$151.16
+1.07%
HEALTHCARE · Cap: $40.10B
MMED
MiniMed Group, Inc. Common Stock
$14.23
+1.21%
HEALTHCARE · Cap: $4.20B
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 617% more annual revenue ($22.23B vs $3.10B). BDX leads profitability with a 5.1% profit margin vs -10.7%. BDX earns a higher WallStSmart Score of 65/100 (B-).
BDX
Strong Buy65
out of 100
Grade: B-
MMED
Avoid35
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+9.9%
Fair Value
$200.45
Current Price
$151.16
$49.29 discount
Intrinsic value data unavailable for MMED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 28.6% YoY
Reasonable price relative to book value
Conservative balance sheet, low leverage
15.6% revenue growth
Areas to Watch
Moderate valuation
ROE of 4.7% — below average capital efficiency
5.1% margin — thin
Distress zone — elevated risk
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Weak financial health signals
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Price/Book, EPS Growth. PEG of 1.11 suggests the stock is reasonably priced for its growth.
Bull Case : MMED
The strongest argument for MMED centers on Price/Book, Debt/Equity, Revenue Growth. Revenue growth of 15.6% demonstrates continued momentum.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Return on Equity, Profit Margin.
Bear Case : MMED
The primary concerns for MMED are EPS Growth, Return on Equity, Piotroski F-Score.
Key Dynamics to Monitor
BDX profiles as a value stock while MMED is a growth play — different risk/reward profiles.
MMED is growing revenue faster at 15.6% — sustainability is the question.
BDX generates stronger free cash flow (546M), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BDX scores higher overall (65/100 vs 35/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →MiniMed Group, Inc. Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?